Institute of Molecular Bioimaging and Physiology, National Research Council, Largo Paolo Daneo, 3, 16132, Genoa, Italy.
Department of Neuroscience (DINOGMI), IRCCS Polyclinic San Martino-IST, University of Genoa, Genoa, Italy.
Eur J Nucl Med Mol Imaging. 2019 Feb;46(2):334-347. doi: 10.1007/s00259-018-4197-7. Epub 2018 Oct 31.
The aim of this study was to verify the reliability and generalizability of an automatic tool for the detection of Alzheimer-related hypometabolic pattern based on a Support-Vector-Machine (SVM) model analyzing F-fluorodeoxyglucose (FDG) PET data.
The SVM model processed metabolic data from anatomical volumes of interest also considering interhemispheric asymmetries. It was trained on a homogeneous dataset from a memory clinic center and tested on an independent multicentric dataset drawn from the Alzheimer's Disease Neuroimaging Initiative. Subjects were included in the study and classified based on a diagnosis confirmed after an adequate follow-up time.
The accuracy of the discrimination between patients with Alzheimer Disease (AD), in either prodromal or dementia stage, and normal aging subjects was 95.8%, after cross-validation, in the training set. The accuracy of the same model in the testing set was 86.5%. The role of the two datasets was then reversed, and the accuracy was 89.8% in the multicentric training set and 88.0% in the monocentric testing set. The classification rate was also evaluated in different subgroups, including non-converter mild cognitive impairment (MCI) patients, subjects with MCI reverted to normal conditions and subjects with non-confirmed memory concern. The percent of pattern detections increased from 77% in early prodromal AD to 91% in AD dementia, while it was about 10% for healthy controls and non-AD patients.
The present findings show a good level of reproducibility and generalizability of a model for detecting the hypometabolic pattern in AD and confirm the accuracy of FDG-PET in Alzheimer disease.
本研究旨在验证一种基于支持向量机(SVM)模型的自动工具检测阿尔茨海默病相关低代谢模式的可靠性和可推广性,该模型通过分析 F-氟脱氧葡萄糖(FDG)PET 数据进行代谢处理。
SVM 模型处理来自解剖学感兴趣区的代谢数据,同时考虑半球间的不对称性。它是在一个记忆诊所中心的同质数据集上进行训练,并在来自阿尔茨海默病神经影像学倡议的独立多中心数据集上进行测试。研究对象根据充分随访后确诊的诊断结果进行分类。
在训练集上,经过交叉验证,该模型在区分阿尔茨海默病(AD)患者(无论是前驱期还是痴呆期)和正常老化患者方面的准确率为 95.8%。在测试集中,相同模型的准确率为 86.5%。然后反转两个数据集的角色,在多中心训练集中的准确率为 89.8%,在单中心测试集中的准确率为 88.0%。还评估了该分类器在不同亚组中的分类率,包括非转化轻度认知障碍(MCI)患者、MCI 恢复正常的患者和无记忆问题的患者。从早期前驱 AD 中模式检测的百分比从 77%增加到 AD 痴呆症中的 91%,而健康对照者和非 AD 患者的百分比约为 10%。
目前的研究结果表明,检测 AD 低代谢模式的模型具有良好的可重复性和可推广性,并证实了 FDG-PET 在阿尔茨海默病中的准确性。